Back to search

Article

Anxiety Disturbs Metabolome of Blood Plasma in Coronary Heart Disease Patients

2021-02-03

Abstract excerpt

Coronary heart disease (CHD) is the result of complex metabolic disorder caused by various environmental and genetic factors, and often comorbidity with anxiety. Anxiety was known to an independent risk factor for the adverse cardiovascular events and mortality in patients with CHD, while how stress-induced anxiety behavior impacts the metabolome of blood plasma in CHD patients and contributes to CHD worse is uncl...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
5c052000-d0bc-59df-b4c3-1890f84e21a6
DOI
10.21203/rs.3.rs-144700/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Anxiety Disturbs Metabolome of Blood Plasma in Coronary Heart Disease PatientsDOI 10.21203/rs.3.rs-144700/v1
The Interactions and Biological Pathways Among Metabolomics Products of Patients with Coronary Heart Disease Analyzed Using the Bioinformatics MethodsSemantic proximity
Genomics of lipid metabolism : identification of genetic determinants of lipid metabolites and the effect of perturbations of lipid levels on coronary heart disease risk factorsSemantic proximity
Indoleacetylglutamine Pathway Is a Potential Biomarker for Cardiovascular DiseasesSemantic proximity
Transformations in Plasma Metabolic Profiles of Patients with Major Depression During Treatment: A Pilot Metabolomics StudySemantic proximity
Circulating Metabolomic Profiling Detects Novel Markers of Myocardial Infarction among Cardiac-chest Pain CasesSemantic proximity
Integrated untargeted/targeted metabolomics identifies a putative oxylipin signature in patients with atrial fibrillation and coronary heart diseaseSemantic proximity
How to Screen and Prevent Metabolic Syndrome in Patients of PCOS Early: Implications From MetabolomicsSemantic proximity
Metabolomic strategies to identify tissue-specific effects of cardiovascular drugs.Semantic proximity
Link between depression and cardiovascular diseases due to epigenomics and proteomics: Focus on energy metabolismSemantic proximity
Metabolite profiles and the risk of cardiometabolic disease.Semantic proximity
Pharmacometabolomics analysis of plasma to phenotype clopidogrel high on treatment platelets reactivity in coronary artery disease patients.Semantic proximity
An Overview of Metabolomics Studies Based on Qatari Population.Semantic proximity
Select a neighboring publication to make it the new centre.